Company / Operating Income per Share
Neogen Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.17
FY2025
5-year range
-$4.91 / $0.64
FY2021-FY2025
Trend
+103.5%
vs FY2024
Sector context
#97 of 154
Health Care
What the data says
At $0.17, Neogen's operating income per share ranks #97 of 154 in the Health Care sector. Operating Income per Share returned to growth in FY2025 after 4 years of decline, reaching $0.17.
Based on SEC 10-K filings.
0.17 in FY2025 with a 5-year CAGR of -33.7%.
Declined from $0.54 to $0.17 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -35.0%
- 5-Year CAGR
- -33.7%
- 10-Year CAGR
- -
Sector benchmark
#97 of 154 in Health CareTop 63% of 154This company $0.17 Sector average $4.25
▼
-95.9% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 103.5% year-over-year.
- Ranks #97 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.17 | +103.5% |
| FY2024 | -$4.91 | -1001.6% |
| FY2023 | $0.54 | -13.4% |
| FY2022 | $0.63 | -2.3% |
| FY2021 | $0.64 | -52.2% |
| FY2020 | $1.34 | +7.1% |
| FY2019 | $1.26 | +13.4% |
| FY2018 | $1.11 | -21.7% |
| FY2017 | $1.41 | +21.0% |
| FY2016 | $1.17 | +5.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026